Free Covid booster dose for all adults: The Centre has started rolling out free Covid-19 booster doses for adults in the 18-59 category at government centres under a special drive. The free booster dose drive will continue for 75 days. The drive aims to improve the third-dose coverage and is being held as part of … Read more
Free booster COVID-19 vaccine Dose for Adults from 15 July: The Union health ministry on Wednesday announced the launch of a 75-day programme to administer the Covid-19 vaccine’s precaution dose to anyone above 18 years, free of cost, at government hospitals from July 15. Till now only those above 60 years, healthcare and frontline workers … Read more
Canada is going to throw out about 13.6 million doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn’t find any takers for it either at home or abroad. Canada signed a contract with AstraZeneca in 2020 to get 20 million doses of its vaccine, and 2.3 million Canadians received at least one dose of it, … Read more
By Robin Foster HealthDay Reporter FRIDAY, June 24, 2022 (HealthDay News) — An expert panel from the U.S. Centers for Disease Control and Prevention voted unanimously on Thursday to recommend that the Moderna COVID-19 vaccine be approved for kids between the ages of 6 and 17. The Advisory Committee on Immunization Practices (ACIP) endorsed the … Read more
An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to Serum Institute’s Covovax for children aged 7 to 11 years, official sources said. The recommendation has been sent to Drugs Controller General of India (DCGI) for final approval. The application for emergency use authorisation was submitted by Prakash Kumar … Read more
Bharat Biotech’s Covid-19 vaccine — Covaxin — has reported higher neutralising antibodies in children and on an average, it was 1.7 times higher than in adults. The vaccine was well-tolerated and immunogenic in paediatric subjects in Phase II/III study. The study has been accepted and published in Lancet Infectious Diseases. Covaxin is one of the … Read more
Over 80 per cent of people aged between 15 and 18 years have received the first dose of Covid vaccine, Union Health Minister Mansukh Mandaviya said on Tuesday. The total number of Covid vaccine doses administered in India exceeded 192.52 crore till Tuesday 7 am, according to a provisional report. The COVID-19 vaccination for the … Read more
The Serum Institute of India (SII) has sought permission from the country’s drug regulator to conduct Phase-3 trial to evaluate the safety and immunogenicity of its COVID-19 vaccine Covovax as a booster dose in children aged two to 18 years, official sources said on Sunday. The Drugs Controller General of India (DCGI) had granted permission … Read more
The Drugs Controller General of India (DCGI) granted emergency use authorisation for Biological E’s Covid-19 vaccine Corbevax for children aged five to 12 years, and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, on Tuesday. The DCGI has also granted emergency use authorisation (EUA) to Cadila for its ZyCoV-D … Read more
Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in The Lancet Global Health journal. The research assessed the effectiveness of CoronaVac, Pfizer and AstraZeneca vaccine boosters in individuals who had … Read more